Discover More:
Why Standards Matter in Digital Therapeutics
Maryland, MD—United States Pharmacopeia (USP) Healthcare Quality and Safety (HQS) Center of Excellence is examining the current landscape of Digital Therapeutics (DTx) to establish quality standards aimed at broadening access and ensuring appropriate use of these therapeutics.
Reflecting on results from four years fighting TB in the Kyrgyz Republic ...
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
Public Health advocates call on policymakers to end drug shortages in the U.S. ...
Drug shortages pose a significant, ongoing threat to our healthcare system and to the patients who rely on medicine for their wellbeing and survival.
Q&A with Mrunal Jaywant: How the Discovery of Nitrosamines in Medicines Shifted the P...
In April, the World Health Organization (WHO) became the latest health authority to release a draft guidance on Current Good Manufacturing Practices (CGMP) considerations for the prevention and management of nitrosamine contamination in pharmaceutical products.